248 related articles for article (PubMed ID: 29843637)
1. ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL.
Wang Y; Guan G; Cheng W; Jiang Y; Shan F; Wu A; Cheng P; Guo Z
BMC Cancer; 2018 May; 18(1):599. PubMed ID: 29843637
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LINC00526 represses glioma progression via forming a double negative feedback loop with AXL.
Yan J; Xu C; Li Y; Tang B; Xie S; Hong T; Zeng E
J Cell Mol Med; 2019 Aug; 23(8):5518-5531. PubMed ID: 31240814
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ARL2 in colorectal cancer cell proliferation and tumorigenicity, and its negative association with AXL.
Pang X; Wang Y; Miao B; Fei S; Chen W
Oncol Lett; 2021 Mar; 21(3):196. PubMed ID: 33574935
[TBL] [Abstract][Full Text] [Related]
4. Exosome-transmitted linc00852 associated with receptor tyrosine kinase AXL dysregulates the proliferation and invasion of osteosarcoma.
Li Q; Wang X; Jiang N; Xie X; Liu N; Liu J; Shen J; Peng T
Cancer Med; 2020 Sep; 9(17):6354-6366. PubMed ID: 32673448
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.
Onken J; Torka R; Korsing S; Radke J; Krementeskaia I; Nieminen M; Bai X; Ullrich A; Heppner F; Vajkoczy P
Oncotarget; 2016 Mar; 7(9):9876-89. PubMed ID: 26848524
[TBL] [Abstract][Full Text] [Related]
6. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells.
Vouri M; An Q; Birt M; Pilkington GJ; Hafizi S
Oncotarget; 2015 Jun; 6(18):16183-97. PubMed ID: 25980499
[TBL] [Abstract][Full Text] [Related]
7. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.
Vajkoczy P; Knyazev P; Kunkel A; Capelle HH; Behrndt S; von Tengg-Kobligk H; Kiessling F; Eichelsbacher U; Essig M; Read TA; Erber R; Ullrich A
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5799-804. PubMed ID: 16585512
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells.
Xu D; Ma P; Gao G; Gui Y; Niu X; Jin B
Tumour Biol; 2015 Sep; 36(10):7743-53. PubMed ID: 25936342
[TBL] [Abstract][Full Text] [Related]
9. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of TET1 Promotes Glioma Cell Proliferation and Invasion by Targeting Wnt/
Ji J; You Q; Zhang J; Wang Y; Cheng J; Huang X; Zhang Y
Anal Cell Pathol (Amst); 2021; 2021():8980711. PubMed ID: 34926132
[TBL] [Abstract][Full Text] [Related]
11. Skipping of exon 10 in
Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
[TBL] [Abstract][Full Text] [Related]
12. Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival.
Teng L; Nakada M; Furuyama N; Sabit H; Furuta T; Hayashi Y; Takino T; Dong Y; Sato H; Sai Y; Miyamoto K; Berens ME; Zhao SG; Hamada J
Neuro Oncol; 2013 Dec; 15(12):1710-20. PubMed ID: 24121831
[TBL] [Abstract][Full Text] [Related]
13. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway.
Ma Y; Zhou G; Li M; Hu D; Zhang L; Liu P; Lin K
Neurochem Int; 2018 Sep; 118():233-241. PubMed ID: 29572052
[TBL] [Abstract][Full Text] [Related]
15. Protein S drives oral squamous cell carcinoma tumorigenicity through regulation of AXL.
Abboud-Jarrous G; Priya S; Maimon A; Fischman S; Cohen-Elisha M; Czerninski R; Burstyn-Cohen T
Oncotarget; 2017 Feb; 8(8):13986-14002. PubMed ID: 28118606
[TBL] [Abstract][Full Text] [Related]
16. A Novel Tumor-Suppressor, CDH18, Inhibits Glioma Cell Invasiveness Via UQCRC2 and Correlates with the Prognosis of Glioma Patients.
Bai YH; Zhan YB; Yu B; Wang WW; Wang L; Zhou JQ; Chen RK; Zhang FJ; Zhao XW; Duan WC; Wang YM; Liu J; Bao JJ; Zhang ZY; Liu XZ
Cell Physiol Biochem; 2018; 48(4):1755-1770. PubMed ID: 30078018
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
[TBL] [Abstract][Full Text] [Related]
18. ACYP2 contributes to malignant progression of glioma through promoting Ca
Li M; Ruan B; Wei J; Yang Q; Chen M; Ji M; Hou P
J Exp Clin Cancer Res; 2020 Jun; 39(1):106. PubMed ID: 32517717
[TBL] [Abstract][Full Text] [Related]
19. CADM2 inhibits human glioma proliferation, migration and invasion.
Liu N; Yang C; Bai W; Wang Z; Wang X; Johnson M; Wang W; Zhang P; Yang H; Liu H; Cheng Y; Tu Y
Oncol Rep; 2019 Apr; 41(4):2273-2280. PubMed ID: 30816549
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
